| Literature DB >> 31835647 |
Abdulkader Masri1, Ayaz Anwar1, Naveed Ahmed Khan2, Ruqaiyyah Siddiqui2.
Abstract
The emergence of drug resistance combined with limited success in the discovery of newer and effective antimicrobial chemotherapeutics poses a significant challenge to human and animal health. Nanoparticles may be an approach for effective drug development and delivery against infections caused by multi-drug resistant bacteria. Here we discuss nanoparticles therapeutics and nano-drug delivery against bacterial infections. The therapeutic efficacy of numerous kinds of nanoparticles including nanoantibiotics conjugates, small molecules capped nanoparticles, polymers stabilized nanoparticles, and biomolecules functionalized nanoparticles has been discussed. Moreover, nanoparticles-based drug delivery systems against bacterial infections have been described. Furthermore, the fundamental limitation of biocompatibility and biosafety of nanoparticles is also conferred. Finally, we propose potential future strategies of nanomaterials as antibacterials.Entities:
Keywords: antibacterial efficacy; drug delivery; nanomedicine
Year: 2019 PMID: 31835647 DOI: 10.3390/antibiotics8040260
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382